Literature DB >> 19408972

Equal contribution of increased intracranial pressure and subarachnoid blood to cerebral blood flow reduction and receptor upregulation after subarachnoid hemorrhage. Laboratory investigation.

Saema Ansar1, Lars Edvinsson.   

Abstract

OBJECT: Cerebral ischemia remains the key cause of disability and death in the late phase after subarachnoid hemorrhage (SAH), and its pathogenesis is still poorly understood. The purpose of this study was to examine whether the change in intracranial pressure or the extravasated blood causes the late cerebral ischemia and the upregulation of receptors or the cerebral vasoconstriction observed following SAH.
METHODS: Rats were allocated to 1 of 3 experimental conditions: 1) cisternal injection of 250 microl blood (SAH Group), 2) cisternal injection of 250 microl NaCl (Saline Group), or 3) the same procedure but without fluid injection (Sham Group). Two days after the procedure, the basilar and middle cerebral arteries were harvested, and contractile responses to endothelin (ET)-1 and 5-carboxamidotryptamine (5-CT) were investigated by means of myography. In addition, real-time polymerase chain reaction was used to determine the mRNA levels for ET(A), ET(B), and 5-HT(1) receptors. Regional and global cerebral blood flow (CBF) were quantified by means of an autoradiographic technique.
RESULTS: Compared with the sham condition, both SAH and saline injection resulted in significantly enhanced contraction of cerebral arteries in response to ET-1 and 5-CT. Regional and global CBF were reduced both in the Saline and SAH groups compared with the Sham Group. The mRNA levels for ET(B) and 5-HT(1B) receptors were upregulated after SAH and saline injection compared with the sham procedure. The effects in all parameters were more pronounced for SAH than for saline injection.
CONCLUSIONS: This study revealed that both the elevation of intracranial pressure and subarachnoid blood per se contribute approximately equally to the late CBF reductions and receptor upregulation following SAH.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19408972     DOI: 10.3171/2007.3.16738

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  14 in total

Review 1.  Vascular plasticity in cerebrovascular disorders.

Authors:  Lars I H Edvinsson; Gro Klitgaard Povlsen
Journal:  J Cereb Blood Flow Metab       Date:  2011-05-11       Impact factor: 6.200

2.  Plasticity of cerebrovascular smooth muscle cells after subarachnoid hemorrhage.

Authors:  Lars Edvinsson; Stine Schmidt Larsen; Aida Maddahi; Janne Nielsen
Journal:  Transl Stroke Res       Date:  2014-01-22       Impact factor: 6.829

3.  MEK1/2 inhibitor U0126 but not endothelin receptor antagonist clazosentan reduces upregulation of cerebrovascular contractile receptors and delayed cerebral ischemia, and improves outcome after subarachnoid hemorrhage in rats.

Authors:  Gro K Povlsen; Lars Edvinsson
Journal:  J Cereb Blood Flow Metab       Date:  2014-11-19       Impact factor: 6.200

4.  The Acute Phase of Experimental Subarachnoid Hemorrhage: Intracranial Pressure Dynamics and Their Effect on Cerebral Blood Flow and Autoregulation.

Authors:  Catharina Conzen; Katrin Becker; Walid Albanna; Miriam Weiss; Annika Bach; Nyanda Lushina; André Steimers; Sarah Pinkernell; Hans Clusmann; Ute Lindauer; Gerrit A Schubert
Journal:  Transl Stroke Res       Date:  2018-11-15       Impact factor: 6.829

5.  Blockade of the MEK/ERK pathway with a raf inhibitor prevents activation of pro-inflammatory mediators in cerebral arteries and reduction in cerebral blood flow after subarachnoid hemorrhage in a rat model.

Authors:  Aida Maddahi; Saema Ansar; Qingwen Chen; Lars Edvinsson
Journal:  J Cereb Blood Flow Metab       Date:  2010-04-28       Impact factor: 6.200

6.  Uncoupling of endothelial nitric oxide synthase after experimental subarachnoid hemorrhage.

Authors:  Mohammed Sabri; Jinglu Ai; Britta Knight; Asma Tariq; Hyojin Jeon; Xueyuan Shang; Philip Anthony Marsden; Robert Loch Macdonald
Journal:  J Cereb Blood Flow Metab       Date:  2010-06-02       Impact factor: 6.200

7.  Multimodal MRI characterization of experimental subarachnoid hemorrhage.

Authors:  Y Sun; Q Shen; L T Watts; E R Muir; S Huang; G-Y Yang; J I Suarez; T Q Duong
Journal:  Neuroscience       Date:  2015-12-18       Impact factor: 3.590

8.  A minimally-invasive rat model of subarachnoid hemorrhage and delayed ischemic injury.

Authors:  Joshua R Dusick; Brandon C Evans; Azim Laiwalla; Scott Krahl; Nestor R Gonzalez
Journal:  Surg Neurol Int       Date:  2011-07-18

9.  Inhibition of cerebrovascular raf activation attenuates cerebral blood flow and prevents upregulation of contractile receptors after subarachnoid hemorrhage.

Authors:  Saema Ansar; Aida Maddahi; Lars Edvinsson
Journal:  BMC Neurosci       Date:  2011-10-27       Impact factor: 3.288

10.  Early events triggering delayed vasoconstrictor receptor upregulation and cerebral ischemia after subarachnoid hemorrhage.

Authors:  Gro Klitgaard Povlsen; Sara Ellinor Johansson; Carl Christian Larsen; Ajoy Kumar Samraj; Lars Edvinsson
Journal:  BMC Neurosci       Date:  2013-03-15       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.